GlaxoSmithKline Pharmaceuticals has reported results for third quarter ended December 31, 2015.
The company has reported 76.38% rise in its net profit at Rs 79.90 crore for the quarter ended December 31, 2015 as compared to Rs 45.30 crore for the same quarter in the previous year. Total income of the company has increased by 10.66% to Rs 762.06 crore for the quarter under review from Rs 688.63 crore for the corresponding quarter of the previous year.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1545.25 |
Dr. Reddys Lab | 5861.00 |
Cipla | 1356.95 |
Zydus Lifesciences | 984.75 |
Lupin | 1635.00 |
View more.. |